Medical testing services for detection, diagnostic or treatment purposes marketed and sold to healthcare providers and insurers, namely, third-party testing of patient urine, blood and/or oral fluids; medical pharmacogenetic testing services for detection, diagnostic or treatment purposes that predict a patient's genetic predisposition to metabolizing medications